The ability of PINK1 to affect mitochondrial fragmentation in neurons via Drp1 leaves open an avenue for possible AD therapy by regulating the expression of PINK1 as a means of controlling fission and fragmentation. This evidence concerns the gene DNM1L and Alzheimer disease.